- Analysts predict an EPS of -$0.19 for Q4 2025, a 32.1% improvement year-over-year.
- Revenue for Q4 2025 is projected at $633.91 million, a slight 1% decline from the previous year.
- The Integrated Care segment is expected to see a 9.1% growth in membership and a 20.9% increase in segment EBITDA year-over-year.
Teladoc Health, Inc. (NYSE:TDOC) is a prominent player in the telehealth industry, providing virtual healthcare services. As the company gears up to release its fourth-quarter 2025 earnings on February 25, 2026, analysts predict an earnings per share (EPS) of -$0.19. This marks a 32.1% improvement from the previous year, indicating some progress in the company’s financial performance.
Revenue for the quarter is projected to be $633.91 million, a slight 1% decline from the same period last year. Despite this decrease, the stability in the consensus EPS estimate over the past month suggests that analysts have maintained their initial projections. This stability is crucial as it often influences investor reactions to the stock, as highlighted by historical data linking changes in earnings estimates to short-term price movements.
Teladoc’s Integrated Care segment is showing promise, with membership expected to grow by 9.1% and segment EBITDA projected to increase by 20.9% year over year. However, the BetterHelp segment faces challenges, with anticipated revenue declines of 6.2% and a 5% decrease in paying users for the fourth quarter. These mixed results highlight the company’s ongoing efforts to balance growth and profitability across its segments.
For the full year 2025, Teladoc’s revenues are estimated at $2.52 billion, reflecting a 1.9% decline from the previous year. Despite these challenges, the slight improvement in the earnings estimate over the past 60 days suggests some optimism about the company’s financial performance. Investors will be keen to see how these factors play out in the upcoming earnings report.
Teladoc’s financial metrics reveal a complex picture. The company has a negative price-to-earnings (P/E) ratio of -3.57, indicating it is not currently profitable. However, a price-to-sales ratio of 0.32 suggests investors are paying $0.32 for every dollar of sales, which may be attractive to some. The debt-to-equity ratio of 0.75 shows a moderate level of debt, while a current ratio of 2.70 indicates a strong ability to cover short-term liabilities.
